Some small-cap companies may appear to be underdogs, but with the right analysis, these companies may be on the fast track to becoming winners. All of the businesses in our list today have been rated as "Strong Buy" by industry analysts. We ran an additional screen to find small caps that have great projected earnings. Take a look at the quick summary below to get an idea of where to start your research.
EPS growth (earnings per share growth) illustrates the growth of earnings per share over time. The 5-Year Expected EPS Growth Rate is a long term annual growth estimate, where the growth projections are made by analysts, the company or other credible sources.
We first looked for small-cap stocks. We then looked for companies that analysts rate as "Strong Buy" (mean recommendation <2). We then screened for businesses with estimated high-growth, with 5-year projected EPS growth above 25%. We did not screen out any sectors.
Do you think these small-cap stocks are in strong positions for future growth? Use our screened list as a starting point for your own analysis.
1) OSI Systems, Inc. (NASDAQ:OSIS)
|Industry:||Semiconductor Equipment & Materials|
OSI Systems, Inc. has Analysts' Rating of 1.50 and a 5-Year Projected Earnings Per Share Growth Rate of 37.00%. The short interest was 3.67% as of 07/27/2012. OSI Systems, Inc., together with its subsidiaries, designs and manufactures electronic systems and components for homeland security, healthcare, defense, and aerospace markets worldwide. The company operates in three divisions: Security, Healthcare, and Optoelectronics and Manufacturing. The Security division provides security and inspection systems under the Rapiscan Systems name.
2) Liquidity Services, Inc. (NASDAQ:LQDT)
|Industry:||Catalog & Mail Order Houses|
Liquidity Services, Inc. has Analysts' Rating of 1.40 and a 5-Year Projected Earnings Per Share Growth Rate of 30.33%. The short interest was 14.19% as of 07/27/2012. Liquidity Services, Inc. operates various online auction marketplaces for surplus and salvage assets in the United States. Its auction marketplaces include liquidation.com, which enables corporations and selected government agencies located in the United States to sell surplus and salvage consumer goods and capital assets.
3) NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)
NPS Pharmaceuticals, Inc. has Analysts' Rating of 1.30 and a 5-Year Projected Earnings Per Share Growth Rate of 80.00%. The short interest was 7.12% as of 07/27/2012. NPS Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for gastrointestinal and endocrine disorders, and various medical needs. The company's primary clinical programs include two therapeutic peptides to restore or replace biological functions comprising GATTEX, a Phase 3 clinical trial product for short bowel syndrome; and Natpara, a recombinant human parathyroid hormone 1-84, which is in Phase 3 clinical development trials. It also develops NPSP790 and NPSP795 calcilytic compounds that are in Phase I trials for the treatment of rare endocrine disorders.
4) The Active Network, Inc. (NYSE:ACTV)
The Active Network, Inc. has Analysts' Rating of 1.30 and a 5-Year Projected Earnings Per Share Growth Rate of 32.50%. The short interest was 6.39% as of 07/27/2012. The Active Network, Inc. provides organization-based cloud computing applications services to business customers in North America, Europe, and internationally. The company offers ActiveWorks, an organization-based cloud computing platform, which transforms the way organizers record, track, manage, and share information regarding activities and events. Its ActiveWorks back-office system pulls customers' participant management, operational reporting, volunteer management, and service and payment processing functions into one hosted system.
5) Team Inc. (NYSE:TISI)
Team Inc. has Analysts' Rating of 1.50 and a 5-Year Projected Earnings Per Share Growth Rate of 27.53%. The short interest was 3.75% as of 07/27/2012. Team, Inc. provides specialty maintenance and construction services for maintaining high temperature and high pressure piping systems and vessels that are utilized in heavy industries. It offers inspection and assessment services, such as inspection and evaluation of piping, piping components, and equipment; field heat treating services, including electric resistance and gas-fired combustion; leak repair services comprising on-stream repairs of leaks in pipes, valves, flanges, and other parts of piping systems and related equipment; and fugitive volatile organic chemical emission leak detection services consisting of identification, monitoring, data management, and reporting. The company also provides hot tapping services, such as hot tapping, Line-stop, and Freeze-stop services; field machining services, including the use of portable machining equipment to repair or modify machinery, equipment, vessels, and piping systems, as well as flange facing, pipe cutting, line boring, journal turning, drilling, and milling services; and technical bolting services comprising the use of hydraulic or pneumatic equipment with bolt tightening techniques for leak-free connections, plant maintenance, and expansion projects, as well as bolt disassembly and hot bolting services.
6) Bona Film Group Limited (NASDAQ:BONA)
|Industry:||Entertainment - Diversified|
Bona Film Group Limited has Analysts' Rating of 1.40 and a 5-Year Projected Earnings Per Share Growth Rate of 45.47%. The short interest was 0.13% as of 07/27/2012. Bona Film Group Limited engages in the distribution of films in the People's Republic of China and internationally. Its film distribution activities include film sourcing, which comprises identifying film projects with commercial potential and securing film distribution rights; print and marketing that includes coordinating the distribution of film prints to theater circuits, as well as conducting marketing and publicity campaigns to promote the films to their target audiences; exhibition, which comprises negotiating the terms of exhibitions of films in domestic and international movie theaters, as well as through non-theatrical distribution channels; and film advertising that includes the sale of advertising time immediately prior to the start of the theatrical screening of a film, in-film product placements, and cross-promotion campaigns. The company is also involved in the film investment and production, television production, and movie theater operation activities; and provision of talent agency services to artists.
7) MAP Pharmaceuticals, Inc. (NASDAQ:MAPP)
|Industry:||Drug Manufacturers - Other|
MAP Pharmaceuticals, Inc. has Analysts' Rating of 1.40 and a 5-Year Projected Earnings Per Share Growth Rate of 49.00%. The short interest was 17.58% as of 07/27/2012. MAP Pharmaceuticals, Inc., a development stage company, focuses on the enhancement of the therapeutic benefits and commercial attractiveness of proven drugs in the field of neurology through its formulation and inhalation technologies. The company's lead product candidate includes LEVADEX, an orally inhaled version of dihydroergotamine mesylate (DHE) that has completed Phase III clinical trials for the acute treatment of migraine in adults. Its proprietary technologies consist of particle creation and formulation technologies, which can be applied to small or large molecules, including peptides and proteins; and aerosol delivery platforms, such as TEMPO inhaler, a pressurized metered dose inhaler (MDI) that dispenses drug automatically when the patient inhales.
*Company profiles were sourced from Finviz. Financial data was sourced from Finviz and Yahoo Finance.